openPR Logo
Press release

Migraine Drugs Market: Analysis Report, Share, Trends and Overview 2021-2027

07-06-2021 11:03 AM CET | Health & Medicine

Press release from: OMR REPORTS

The global migraine drugs market is estimated to grow at a CAGR of over 9% during the forecast period. The market growth is attributed to the rising incidences of migraines, extreme exposure to screens and stressed lifestyles, presence of robust pipeline, and increasing R&D expenditures. Further, the development of novel drugs and the approvals by the US FDA is expected to provide growth opportunities to the market in the near future.

A full report of Migraine Drugs Market is available at: https://omrreports.com/migraine-drugs-market/48615/

Scope of the Report

• Comprehensive research methodology of the market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Insights about market determinants.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

To learn more about this report request a sample copy @ https://omrreports.com/request-sample/?id=48615

Migraine Drugs Market- Segmentation

By Treatment Type

• Acute Migraine Treatment
• Preventive Migraine Treatment

By Route of Administration

• Oral Administration
• Injectable Administration
• Other Administrations Such As Spray

Negative Pressure Wound Therapy (NPWT) Market– Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Allergan Plc
• Amgen Inc.
• Eli Lilly & Co.
• Novartis International AG
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co. Inc.
• Pfizer Inc.

Media Contact:

Company Name: OMR REPORTS
Contact Person: Mr. Anurag Tiwari
Email: info@omrreports.com
Contact no: +91 780-304-0404

About OMR Reports

OMR Reports endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Migraine Drugs Market: Analysis Report, Share, Trends and Overview 2021-2027 here

News-ID: 2322076 • Views:

More Releases from OMR REPORTS

Electrocardiograph Market Report 2021: By Key Players, Type, Share and Forecast …
The global ECG market is expected to grow at a CAGR of 6.0% during the forecast period. Electrocardiograph (ECG) is a non-invasive medical test that tracks the electrical activities of the heartbeat over a period of time. According to WHO, cardiovascular diseases are among the major cause of mortality across the globe. Among all global mortalities, 31% of them are caused due to CVDs. To observe various information regarding heart
Disposable Medical Sensors Market to 2027, Future Outlook, COVID-19 Impact Analy …
The global disposable medical sensors market is projected to witness a considerable growth rate by exhibiting a significant CAGR of 10.1% during the forecast period. There are various key factors that are contributing to market growth, such as technological advancement in medical industry, increasing demand for remote patient monitoring devices, and rising geriatric population. A full report of Disposable Medical Sensors Market is available at: https://omrreports.com/disposable-medical-sensors-market/49213/ Scope of the Report The global disposable
Digital Pathology Market: Analysis Report, Share, Trends and Overview 2021-2027
The global digital pathology market is anticipated to grow at a significant CAGR during the forecast period. Digital pathology devices serve as important tools for pathologists. The accomplishments in the digital pathology field have improved the workflow of labs, thereby enhancing the pathologist’s role in diagnostics. In addition, digital pathology devices are majorly being used in the R&D of personalized targeted medications. Improvement has been witnessed in the performance of
Dialysis Equipment Market Trends, Research Report, Growth, Opportunities, Foreca …
The global dialysis equipment market is anticipated to grow with a significant CAGR of 6.1%, during the forecast period. Generally, dialysis is needed when end-stage kidney failure is developed, by this time the patient loses about 85-90% of their kidney functions and has a GFR (Glomerular filtration rate) of less than 15. Dialysis equipment uses a special fluid containing a mixture of pure water and chemicals to carefully eliminate the

All 5 Releases


More Releases for Migraine

Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share? The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size? The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market? The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes. Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market. The objectives outlined in the report are multifaceted and aimed at offering a comprehensive
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /